Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2012 · 10-Q
Revenue$3.09B$3.09B+5.2% vs Q3 2011 Net Income$290.40M$290.40M+9.4% vs Q3 2011 EPS Diluted$0.79$0.79+14.5% vs Q3 2011 Gross Profit$1,298,400,000+6.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$479,900,000+33.0% Free Cash Flowderived$403,900,000+35.6% Margins · derivedGross margin42.1%+0.5 pt vs Q3 2011
Operating margin11.4%+0.6 pt vs Q3 2011
Net margin9.4%+0.4 pt vs Q3 2011
ended Sep 29, 2012 · filed Nov 2, 2012 · 34 d after period end